adaptivebiotech.com (ADPT) Company Sales Volume
A stable staff of leading bioinformaticians and scientists ensures the preservation of Adaptive Biotechnologies (ADPT) intellectual capital. The business relies on the synergy between clinical diagnostics and pharmaceutical collaborations, minimizing financial risks. Leadership in immunomics is driven by the implementation of AI and DNA sequencing. The company's sales volume dynamics reflect market trends, where the current figure stands at 0.30, allowing for an assessment of revenue growth sustainability.
Comprehensive metric breakdowns and analytics for Adaptive Biotechnologies Corporation (ADPT)
- price and consensus price forecast:
- market capitalization details:
- issuer book value statistics:
- debt and solvency information:
Debt to Equity Ratio Adaptive Biotechnologies|ADPT - Long-Term Debt to Capital|Short-Term Debt to Capital Adaptive Biotech|ADPT - Company Debts|Debts to Book Capitalization Ratio Adaptive Biotechnologies Corporation|ADPT - Company Long-Term Liabilities|Amount of Current Liabilities Adaptive Biotechnologies|Interim Coverage Ratio adaptivebiotech.com
- business earnings and investment ratios data:
ADPT - Net Income|Expected Profit Adaptive Biotechnologies|ADPT - P/E Multiple|Projected Price to Earnings Ratio adaptivebiotech.com|ADPT - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Adaptive Biotechnologies Corporation|ADPT - Operating profit EBITDA|Earnings per share for the last twelve months Adaptive Biotechnologies|ADPT - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months adaptivebiotech.com|ADPT - Earnings per share growth in current year|Expected net earnings per share growth next year Adaptive Biotechnologies
- company sales and revenue statistics:
Comprehensive company analysis:Adaptive Biotechnologies Inc. (ADPT)
The reliability assessment of equity assets is based on cash flow analysis, where revenue dynamics serve as the primary indicator of market demand. Aggregating daily proceeds from product sales allows for an evaluation of the monetization of Adaptive Biotechnologies (ADPT) unique patent portfolios, confirming the business's resilience against competitors through the company's current sales volume.
Competing companies
Revenue and Sales Volume argenx BVBA|Company Revenue BioNTech SE (BNTX)|Abivax SA - Company Sales Volume|Revenue and Sales Volume ADMA (ADMA Biologics, Inc.)|Protagonist Therapeutics, Inc. (PTGX) - Company Total Revenue|Immunovant Corp - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|GRFS: Revenue and Sales Volume|Company Sales Volume CLDX|AUPH (Aurinia Pharmaceuticals Inc.) - Revenue and Sales Volume|Revenue and Sales Volume BioCryst Pharmaceuticals, Inc.|Company Revenue Vera Pharma (VERA)|DNTH: Company Annual Revenue|Pharvaris N.V. - Company Sales|Company Total Sales ABCL (abcellera.com)|Tourmaline Bio - Revenue and Sales Volume|Company Gross Revenue Precigen Inc PGEN|PHAR (Pharming) - Company Sales|NKTR (Nektar Corp) - Company Revenue|UPB (Upstream Bio Inc) - Revenue and Sales Volume|Company Total Revenue zenasbio.com ZBIO|Company Sales IMNM (Immunome)|GOSS (Gossamer Bio Inc) - Company Sales Revenue|Revenue and Sales Volume KALV (KalVista Pharmaceuticals Inc)|Septerna Pharma - Company Revenue|Pieris Pharmaceuticals - Revenue and Sales Volume|Company Gross Revenue savarapharma.com SVRA|Rigel Pharmaceuticals, Inc. (RIGL) - Company Revenue|Company Total Revenue AnaptysBio Inc (ANAB)|Company Sales ATXS|ENGN (enGene Corp) - Company Total Sales|Revenue and Sales Volume RAPT|JBIO - Company Total Revenue|Revenue and Sales Volume ACRS (Aclaris Therapeutics, Inc.)|KYTX - Company Sales|Tiziana Life Sciences PLC - Revenue and Sales Volume|Company Sales Revenue CABA (Cabaletta Bio Inc)|Ventyx Biosciences (VTYX) - Company Revenue|Company Sales Volume THTX|Company Revenue Avalo Therapeutics|Company Total Revenue Eledon Pharmaceuticals Inc. ELDN|Company Revenue Agenus Inc (AGEN)|Company Revenue CLYM (Climb Bio, Inc)|Company Revenue Zura Bio Limited ZURA|atyrpharma.com (ATYR) - Company Total Revenue|Adagene Corp - Revenue and Sales Volume|Company Total Sales Volume ImageneBio Inc (IMA)|STTK: Revenue and Sales Volume|EQ - Company Gross Revenue|CNTB (Connect Biopharma Holdings) - Revenue and Sales Volume|Company Total Revenue Immunic Inc IMUX|Company Revenue Atara Biotherapeutics (ATRA)|Company Gross Revenue inflarx.de|Revenue and Sales Volume XFOR (X4 Pharma)|Revenue and Sales Volume Adicet Bio Inc. ACET|Celularity Corp - Revenue and Sales Volume|INMB (inmunebio.com) - Company Sales Volume|Barinthus Biotherapeutics plc (BRNS) - Company Revenue|Company Annual Revenue KZR (Kezar Life Sciences Inc.)|Company Sales SABS|AKTX (Akari Therapeutics, Plc) - Company Total Sales|Company Revenue Enlivex Therapeutics (ENLV)|QTTB: Company Annual Revenue|Revenue and Sales Volume GOVX (GeoVax)|Company Sales Revenue EDSA|iBio Corp - Revenue and Sales Volume|CARM - Revenue and Sales Volume|XTL Biopharmaceuticals (XTLB) - Company Revenue|Bolt Biotherapeutics, Inc. - Company Sales Revenue|Company Revenue HCW Biologics, Inc.|Company Sales Aptevo (APVO)|Revenue and Sales Volume AIM|Revenue and Sales Volume aditxt.com (ADTX)|GRI Bio, Inc. - Company Sales|Company Sales Revenue XRTX|Vyome Holdings - Revenue and Sales Volume|Company Gross Revenue Revelation Biosciences Inc REVB|Indaptus (INDP) - Company Revenue|Company Sales BiondVax Pharmaceuticals|Company Revenue CalciMedica Inc|Company Sales Affimed Therapeutics (AFMD)|Company Sales ALLK (Allakos Inc.)|Revenue and Sales Volume hookipapharma.com (HOOK)|Company Revenue IGM Biosciences IGMS|ITOS: Company Sales Volume|Ocean Biomedical, Inc. - Revenue and Sales Volume|Company Total Revenue tcbiopharm.com|THRD: Revenue and Sales Volume
